Venture Visionary Partners LLC Dexcom Inc Transaction History

Venture Visionary Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	BUY	$67.99 - $132.89 $74,721 - $146,046	1,099 Added 223.83%	1,590 $118,000
Q1 2022 May 03, 2022	BUY	$94.08 - $130.2 $188 - $260	2 Added 0.41%	491 $251,000
Q4 2021 Feb 08, 2022	BUY	$129.87 - $162.82 $6,103 - $7,652	47 Added 10.63%	489 $262,000
Q3 2021 Oct 20, 2021	BUY	$106.71 - $143.18 $47,165 - $63,285	442 New	442 $244,000
Q2 2021 Aug 05, 2021	SELL	$80.99 - $107.93 $99,374 - $132,430	-1,227 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$84.79 - $104.74 $13,396 - $16,548	158 Added 14.78%	1,227 $440,000
Q4 2020 Jan 27, 2021	BUY	$78.0 - $104.5 $83,382 - $111,710	1,069 New	1,069 $395,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Venture Visionary Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Venture Visionary Partners LLC with notifications on news.